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Abstract
Bacteriorhodopsin has a polar cluster of amino acids surrounding the retinal molecule, which is responsible for light
harvesting to fuel proton pumping. From our previous studies, we have shown that threonine 90 is the pivotal amino acid in
this polar cluster, both functionally and structurally. In an attempt to perform a phenotype rescue, we have chemically
designed a retinal analogue molecule to compensate the drastic effects of the T90A mutation in bacteriorhodopsin. This
analogue substitutes the methyl group at position C13 of the retinal hydrocarbon chain by and ethyl group (20-methyl
retinal). We have analyzed the effect of reconstituting the wild-type and the T90A mutant apoproteins with all-trans-retinal
and its 20-methyl derivative (hereafter, 13-ethyl retinal). Biophysical characterization indicates that recovering the steric
interaction between the residue 90 and retinal, eases the accommodation of the chromophore, however it is not enough for
a complete phenotype rescue. The characterization of these chemically engineered chromoproteins provides further insight
into the role of the hydrogen bond network and the steric interactions involving the retinal binding pocket in
bacteriorhodopsin and other microbial sensory rhodopsins.
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Introduction
Retinal-related proteins are chromoproteins represented among
the Archaea, Eubacteria and Eukarya domains, working either as
sensors or as ion pumps [1]. These membrane proteins do not only
share the binding of a retinal chromophore through a protonated
Schiff Base (SB), but they also share a common fold of seven
transmembrane helices as revealed by currently available X-ray
crystallographic structures [2,3,4,5,6]. Bacteriorhodopsin (bR)
from Halobacterium salinarum is a protein that converts light energy
absorbed by a retinal molecule (covalently linked through
a protonated SB to Lys216, Figure 1) into a proton electro-
chemical gradient across the membrane [7,8,9]. The disposition in
the membrane of H. salinarum consists of a honeycomb lattice of
bR trimers forming a natural 2D crystal, known as the purple
membrane (PM) [10,11,12].
Bacteriorhodopsin presents two different ground state forms,
known as the dark (DA) and light-adapted (LA) states. In the LA
state the retinal adopts an all-trans configuration, with a negligible
fraction of other retinal isomers [13]. Under this condition the
absorption of light induces the ultrafast retinal isomerization to 13-
cis, followed by a thermal relaxation process involving changes in
the retinal and in the protein conformation known as the
photocycle, resulting in the net transfer of one proton from the
cytoplasm to the extracellular side of the membrane. The
photocycle ends with the recovery of the ground state conforma-
tion containing all-trans retinal in less than 30 ms at room
temperature [14].
In the dark the LA state relaxes thermally in around 20 minutes
at 35uC to the most stable DA state, [15] consisting of an
equilibrium mixture of 13-cis and all-trans retinal in an 2:1 ratio.
The photocycle of 13-cis-retinal involves the isomerization to all-
trans-retinal, which relaxes unproductively within few milliseconds,
eventually leading to the complete light adaptation of bR.
Mutation of residues in the retinal binding pocket (RBP) or the
use of artificial retinal analogues can alter the retinal isomeric
composition in the DA and LA forms of bR as well as the rate of
dark adaptation [16,17,18].
Some of our previous studies have shown that Thr90, a residue
not directly involved in the proton-pump photocycle, is important
to preserve the structure, the proton-pump activity, and the
normal photocycle of bR [19,20]. The Thr90 hydroxyl group is
involved in an inter-helical hydrogen bond with Asp115 side chain
and an intra-helical hydrogen bond with Trp86. It is also in steric
contact with the retinal molecule, where the methyl group of
Thr90 side chain contacts with the retinal hydrocarbon chain,
specifically with the C13-methyl group of the retinal (Figure 1). As
deduced from the D115A mutant, the Thr90-Asp115 interaction
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plays no evident structural role [21] even though it contributes to
the thermal stability of bR [20]. The loss of the Thr90-Asp115
interaction in the D115A mutant has no detectable effect in the
retinal isomeric composition of the LA and DA forms [22];
moreover, the architecture of the RBP is not altered [21]. The
mutant D115A displays nevertheless an altered behavior on its
photocycle, highlighting the functional/dynamical role of the
inter-helical Thr90-Asp115 interaction [22].
The T90A mutation abolishes simultaneously all three men-
tioned interactions of Thr90 with Asp115, Trp 86 and the C13-
methyl retinal, with relevant effects on the structure and
photocycle of bR and in the paracrystalline arrangement of the
PM. Mutation of Thr90 to Ala also affects dramatically the light to
dark adaptation process [19,20]. Interestingly, T90A has also been
reported to be unstable for crystallization [21]. The mutant T90V,
designed to maintain the interaction with the C13-methyl while
losing those with Asp115 and Trp86, partially rescued some of the
alterations observed in T90A [20].
Here, to further assess the structural and functional importance
of the interaction of the retinal C13-methyl with Thr90 we have
substituted the endogenous retinal by the analogue 13-ethyl
retinal. Thus, the apoprotein form (bacterioopsin, bOp) of WT
and T90A was reconstituted with either all-trans retinal (AT) or the
analogue 13-ethyl retinal in trans configuration (13E-RET). Then,
we characterized by diverse biophysical methods the behavior of
these four forms in order to examine whether the extra group on
C13, which should facilitate its interaction with Ala90, could
restore some properties of WT in the T90A mutant.
Materials and Methods
Synthesis of Trans-13-ethylretinal (13E-RET)
For the stereoselective synthesis of trans-13-ethylretinal 1, we
selected the Wittig reaction for the construction of the C7–C8
bond (Figure 2). The introduction of the ethyl group at position
C13 was achieved by the Kumada-Tamao-Corriu cross coupling
reaction catalized by Ni [23,24]. Reaction between the already
described bromide 2 [25] and ethyl magnesium bromide and
subsequent oxidation of the alcohol obtained under basic
conditions afforded trienal 4 in good yield. Wittig olefination of
this aldehyde with the already described phosphonium salt 3 [26]
afforded with complete selectivity the protected alcohol 5 in 70%
yield; the product of the addition of base (n-BuLi) to the aldehyde
4 was also detected. Finally, deprotection of 5 with n-Bu4NF and
rapid oxidation of the alcohol 6 with MnO2 under basic conditions
did not prevent partial isomerization and afforded 13-ethylretinal
1 as a mixture of 13E/13Z isomers in a 2:1 ratio, which were
separated by HPLC (Preparative Nova PakH HR silica, 60 A˚,
196300 mm, 95:5 hexane/EtOAc as eluent). Further information
for the synthesis is provided in Methods S1.
Expression and Photobleaching of the Purple Membrane
Purple membranes from T90A and from WT bR were
expressed and purified from H. salinarum as described [27]. For
retinal SB hydrolysis and removal from the RBP (protein
bleaching), a stirred aqueous suspension of 10 mL containing
7 mg of PM was reacted with 1 M hydroxylamine hydrochloride
at pH 7.5 and room temperature under continuous illumination
(800 lux) for 3 hours. The bleached protein was centrifuged and
washed three times in phosphate buffer (50 mM, pH 6.5) to
remove the free retinal-oxime in the solution, and it was finally
resuspended in 3 mL of the same buffer. A small fraction of the
hydrolyzed retinal-oxime remained in the RBP or interacting
with the bOp even after extensive washing, as evidenced by an
UV-Vis broad band around 350 nm characteristic of retinal-
oxime [27].
Reconstitution of bOps with All-trans and 13-ethyl retinal
Suspensions of bOp (1.061025 M) in phosphate buffer
(50 mM, pH 6.5) were incubated with 1.5 equivalents of AT or
the analogue 13E-RET dissolved in ethanol as described [28]. The
rate of formation of the pigment with AT or 13E-RET was
Figure 1. bR tridimensional structure. A. Surface and cartoon representation of bR (pdb code 1c3w) indicating the most relevant residues for
this study and for proton transport. Surface coloring is coded by element (C, white; O, red: N, blue; S, yellow). In the expanded view, the interacting
methyl groups are indicated in gold color.
doi:10.1371/journal.pone.0042447.g001
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determined from the absorbance increase of the reconstituted
pigment at its maximum absorbance wavelength, at around
570 nm.
Asp85 pKa of the Retinal-reconstituted bOps
Retinal-reconstituted bOps in non-buffered conditions were
microtitrated in the pH range from 7.5 to 2 by addition of small
volumes of HCl or NaOH 0.1 M. After every pH change an UV-
vis spectra was recorded. Protonation of the Asp85 causes a red-
shift in the retinal absorbance, the so-called purple-to-blue form
transition [29]. The corresponding absorbance changes at 615 nm
as a function of pH were used to monitor this transition, and to
determine the pKa of Asp85 fitting the Henderson-Hasselbach
equation to the data.
Schiff Base Hydrolysis and Retinal Release by
Hydroxylamine Hydrochloride
Suspensions of 1.061025 M reconstituted bOp with AT or
13E-RET were treated with 40 mM hydroxylamine hydrochloride
at pH 7.5 in buffer NaPi 5 mM in the dark. UV-Vis spectra were
taken at different time intervals to follow the kinetics of the SB
hydrolysis. The decay with time of the absorbance changes at the
maximum wavelength (lmax) of the pigments followed a mono-
exponential equation, and its half-lifetime constant t1/2 was
estimated.
Thermal Stability
Analysis of thermal stability of dark-adapted samples at
0.7561025 M in phosphate buffer was carried out by recording
absorption spectra in the UV-visible range as a function of
temperature as described earlier [30]. The absorbance changes at
the lmax of the pigment band in the visible region vs. temperature
were fitted to a sigmoidal equation yielding a Tm.
Photocycle Characterization of Retinal-reconstituted
bOps by Flash Photolysis UV-Vis Spectroscopy
Flash-induced transient absorbance changes were monitored as
described [20]. Photocycle reactions of purple membrane suspen-
sions of retinal-reconstituted bOps at pH 7.0 in 3 mM sodium
phosphate buffer and 150 mM KCl were followed by the transient
absorbance changes at 410 nm for M intermediate, at 570 nm for
the BR state, and at 660 nm for O intermediate as a function of
time. Transient pH changes associated with the proton uptake and
release in the bR photocycle were monitored using the pH probe
pyranine. Flash-induced transient absorbance changes of protein
suspensions in 150 mM KCl at pH 7.2 were measured in the
presence of 50 mM pyranine at 460 nm, subtracting the response
of the sample in the absence of the pH dye. The absorbance curves
were normalized according to the apoprotein concentration
determined by means of the absorbance at 280 nm in the UV
spectrum.
Results
Incorporation of Retinal and Light-dark Adaptation
In the present study, our approach consisted in removing the
retinal molecule yielding the apoprotein form of bR (bOp). After
retinal removal, we monitored the incorporation of the AT and
13E-RET to the WT-and T90A-bOp by UV-Vis spectroscopy
(Figure 3). The reconstituted T90A shows a blue-shifted absor-
bance maximum compared to the reconstituted WT, indicative for
a different pocket accommodation for the analogue in T90A.
Likewise, the spectrum of T90A reconstituted with 13E-RET
indicates a more native-like retinal environment compared to
T90A reconstituted with RET (550 nm for T90A-13E-RET and
546 nm for T90A-AT; Figure 3 and Table 1). On the other hand,
a delay/acceleration in the rate of retinal incorporation suggests
unfavourable/favourable retinal-protein interactions in the RBP of
the bOp. The incorporation of AT to the WT-bOp was taken as
the reference. It showed a half-lifetime of 0.9 minutes, whereas the
reconstitution with 13E-RET showed a reconstitution rate of
about 9-fold longer (Table 1). The accessibility of the RBP was
restricted for T90A-bOp when compared to WT-bOp, as
indicated by its ,11-fold longer half-lifetime for AT incorpora-
tion, or the ,13-fold longer lifetime for 13E-RET incorporation
(Table 1).
The DA absorbance maximum for WT-bOp reconstituted with
AT after overnight incubation in darkness at room temperature
was 558 nm, 10 nm blue shifted in respect to the LA form, in
agreement with the observed value for WT bR [15]. This
wavelength arises from the isomeric mixture of 13-cis (550 nm) and
Figure 2. Synthesis overview. a) EtMgBr, NiCl2(dppp), THF, 0 to 40uC, 66%; b) MnO2, CH2Cl2, 25uC, 79%; c) n-BuLi, THF, aldehyde 4,278 to 0uC, (6,
70%; 7, 16%); d) n-Bu4NF, THF, 25uC; e) MnO2, Na2CO3, CH2Cl2, 25uC, 60% both steps.
doi:10.1371/journal.pone.0042447.g002
Probing a Polar Cluster in Bacteriorhodopsin
PLoS ONE | www.plosone.org 3 August 2012 | Volume 7 | Issue 8 | e42447
all-trans (568 nm) retinal, present in a 2:1 ratio in the DA state
[31]. After illumination (light adaptation), this maximum shifted to
568 nm as a result of the nearly complete conversion of the 13-cis
to all-trans-retinal chromophore (Table 1).
The DA form of T90A-AT (one month in darkness) showed
only a 2 nm shift in the absorbance maximum in respect to the LA
form, and a slightly decreased extinction molar coefficient [20],
suggesting defective light-adaptation. Indeed, the retinal isomeric
composition in both the LA and DA states was approximately the
same and similar to WT bR in the DA state as seen by HPLC
(Figure S1 and Methods S1). This shows that mutation of Thr90 to
Ala favors the 13-cis-retinal isomer and impairs the normal
isomerization of the 13-cis-retinal to all-trans retinal by light. The
same abnormal light adaptation behavior was observed for T90A-
Figure 3. Retinal reconstitution assay. Spectra of the UV-Vis absorbance of the WT and T90A bOp after incubation with all-trans retinal and 13-
ethyl retinal in 50 mM phosphate buffer at pH 6.5. The bOp concentration is 1.061025 M and the retinal was added to have a molar ratio 1:1.5 bOp/
retinal. The band at 380 nm (*) is related with the absorbance of the free retinal. The bands that appear in the region of 500–600 nm (**) correspond
to the retinal that has reached the RBP of the corresponding bOp and formed a protonated SB.
doi:10.1371/journal.pone.0042447.g003
Table 1. Characterization of the reconstituted wt-bOp and T90A-bOp with AT retinal and the analogue 13E-RET.
WT-AT T90A-AT WT-13E-RET T90A-13E-RET
lmax pigment (nm)
a 568 546 558 550
t1/2 reconstitution (min)
b 0.960.03 10.260.1 7.960.5 11.660.5
Light-adaptation (nm)c 558(DA)-568(LA) Not observed Not observed Not observed
t1/2 NH2OH (h)
d 6.160.003 5.160.02 4.160.001 3.760.02
Ta denat. pH 7 (uC)e 96.060.6 87.160.3 88.162.1 86.360.9
pKa H2O
f 4.6 6.1 4.7 6.7
pKa KCl 150 mM
g 3.9 5.8 4.5 6.4
Transport h 100% ,10% 26% ,,10%
aMaximum absorbance in the visible spectrum of the bound retinal.
bHalf-life for the reconstitution of the bOps with all-trans and 13E-RET.
cChange in the absorbance maximum of the pigment band after incubation of the chromoproteins in the dark. DA, dark-adapted; LA, light-adapted.
dHalf-life of hydrolysis of suspensions 10 mM of chromoprotein with 40 mM NH2OH in 5 mM phosphate buffer.
eTm of thermal denaturation of the proteins measured as the retinal release with temperature.
fpKa of Asp85 in water.
gpKa of Asp85 in 150 mM KCl.
hIndirect measurement of the proton transport function in the chromoproteins measured as the light-induced transient absorbance change of a 15 mM protein
suspension in the presence of 50 mM pyranine dye.
doi:10.1371/journal.pone.0042447.t001
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13E-RET, showing only a ,2 nm shift upon a month in the dark.
WT-13E-RET shows also this unusual behavior (Figure S2 and
Figure S3) [32].
Stability of Reconstituted Proteins
Chemical and thermal stabilities of the retinal-reconstituted
bOps were monitored by UV-Vis spectroscopy. The reaction of
hydroxylamine in the dark shows a half-lifetime of 6.1 hours for
WT-AT compared to 5.1 hours for T90A-AT (Figure 4A and
Table 1). The accessibility of hydroxylamine for the proteins
reconstituted with the 13E-RET analogue was slightly increased
since the hydrolysis occurred with a lower half-lifetime (4.1 and
3.7 hours for WT-13E-RET and T90A-13E-RET, respectively;
Figure 4A and Table 1). Selected spectra for the chemical
stability analysis are shown in Figure 4B. The minus second
derivative is also represented to better characterize the
hydrolysis kinetics, highlighting the differences between samples
(lower panels in Figure 4B). For the sake of clarity, the spectral
region between 250–450 nm is not displayed, because of the
background absorbance of the retinal oxime and its low signal-
to-noise ratio. The absorbance band of the pigment in the
reconstituted WT-AT chromoprotein was composed of two
main bands with a maximum at 552 and 571 nm. For WT-
13E-RET both peaks were slightly blue-shifted, but for T90A-
bOp reconstituted with AT or 13E-RET there was only one
band at 556 and 559 nm, respectively. However, for T90A-13E-
RET the two bands were present in the intermediate species
that appear along the reaction, with a position in the spectrum
similar to WT-AT.
In the case of the RBP thermal stability, the retinal was released
with a Tm of 96.0uC for WT-AT compared to 87.1uC for T90A-
AT (Table1 and Fig. 5A). This decreased RBP stability for the
T90A-AT agrees with the trend shown previously for T90A [19].
There was virtually no difference between T90A-AT and T90A-
13E-AT (87.1 and 86.3uC, respectively; Table 1). Selected spectra
for the thermal stability analysis are shown in Figure 5B. The
minus second derivative (Figure 5B lower panels) showed a blue
shift of the main bands for WT-13E-RET, T90A-AT and T90A-
13E-RET compared to WT-AT, as described previously for the
hydroxylamine reaction. However, the main peak is less blue-
shifted in the T90A-bOp reconstituted with 13E-RET compared
to T90A-AT (561 and 557 nm, respectively). The thermal
transitions at the maximum absorbance peak are shown in
Figure 5A.
Another main difference between the reconstituted WT and
T90A-bOps is the region at 600–700 nm. This spectral region also
reflects environmental changes in Asp85, the counterion of the
protonated SB (further results on Asp85 below). Taking both
chemical/thermal denaturation experiments into account, we can
observe that for WT reconstituted proteins this region shows
a single transition centered at 625 nm, the spectra for T90A
reconstituted proteins show a more complex profile (Fig. 4B and
5B). The broader bandshape for T90A at the low energy range
region (600–700 nm) argues for a distorted SB and Asp85
environments, even indicating partial protonation of the Asp85
(see Asp85 pKa results below).
Asp85 Environment
The pKa of Asp85 is a sensitive parameter to probe the
environment of the RBP, and specially the interaction of Asp85
with the retinal SB [33]. As shown in Table 1, the pKa values for
WT-AT in deionised water and 150 mM KCl buffer were 4.6 and
3.9 respectively. For T90A-AT, these values rose to 6.1 and 5.8,
respectively. The difference of about 1.5–2 pH units between WT
and T90A, agrees with the difference observed for the WT and
T90A bRs [19], indicating that the retinal environment in the
vicinity of the SB is distorted for the T90A-AT, in a way that
destabilizes the ionic form of Asp85.
In T90A-13E-RET, the pKa of Asp85 was slightly affected by
the 13E-RET-protein contacts when compared to T90A-AT, both
in low and high ionic strength (Table 1). In view of that, one can
say that the substitution of AT by 13E-RET in the T90A mutant
did not recover the Asp85 native environment. Taking into
account the previous results on chemical/thermal denaturation
experiments (see above), it is evident that the incorporation of the
13E-RET to the T90A RBP affects directly the Asp85 and SB
environments.
Photocycle and Transport
Flash-Photolysis UV-Vis spectroscopy was used to monitor
the absorbance transient changes related to different photocycle
intermediates. As shown in Fig. 6 (left panels), WT-13E-RET
has a slightly faster M intermediate decay compared to WT-AT,
in keeping with previous reports [34]. Both T90A-AT and
T90A-13E-RET showed similar M intermediate formation
kinetics, faster than WT. However, the decay showed at least
two components for T90A-13E-RET, and although the first
component forms faster (Fig. 6), the second has a longer lifespan
(about 2-times) than T90A-AT. The O intermediate kinetics
was distorted for both T90A-AT and T90A-13E-RET, com-
pared to each other and compared to WT-AT (Fig. 5 mid
panels). The abnormal high transient absorbance changes in the
early time for T90A are likely to come from the contribution of
the photocycle of the 13-cis retinal, which gives rise to a K-like
intermediate relaxing to the ground-state without SB deproto-
nation, and thus without proton transport [35]. This K-like
intermediate contains an all-trans retinal, and thus similar
absorption maxima as the O intermediate of the normal all-
trans photocycle. A delay in BR recovery was observed for
reconstituted T90A compared to WT (Fig. 6 right panel), in
accordance with the slower decay of the M intermediate. The
maximum transient absorbance changes at 560 nm are lower
for T90A-AT tan for WT-AT, pointing towards less bR
molecules entering into the photocycle for the same laser
excitation energy, and thus for a lower quantum yield for
retinal photo-isomerization. Reconstitution with 13E-RET in-
creases the transient absorbance changes for T90A at 560 nm,
suggesting a recovery to WT levels of the quantum yield for the
retinal photo-isomerization. Proton uptake and release in the
bR photocycle were probed by the protonation changes of
pyranine, monitored by pyranine transient absorbance changes
in the visible. The magnitude of pyranine absorbance changes
was measured, and used as an indirect indication of proton
transport efficiency (Table 1), indicating lower transport
efficiency (of about 10% of WT) for both reconstituted T90A
proteins. WT-13E-RET showed slightly better transport than
T90A reconstituted proteins, about 26% of WT (Table 1). Part
of this decrease in transport efficiency can be accounted for by
the presence in the LA form of T90A and WT-13E-RET of 13-
cis retinal, whose photocycle is inactive for proton pumping. In
addition, the fraction of molecules with protonated Asp85,
larger for T90A than for WT due to the higher pKa of Asp85,
will be impaired for proton transport (see Asp85 environment
section). Additional contribution to the reduced transport
efficiency can arise from reduced quantum efficiency for retinal
photo-isomerization or reduced protein stability.
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Discussion
The architecture of a functional active site of a membrane
protein is not only defined as the result of its close environment,
but also by the overall topology in the membrane. The case of
retinal proteins is not an exception. However, we can restrict the
chromophore as the core of the protein, assuming the network of
interactions established between the retinal and the protein as the
initial and pivotal factor for the outwards propagation of the signal
from the retinal to the rest of the protein and its arrangement in
the membrane. Here, in an attempt to perform a phenotype
recovery of the T90A mutant, we have used a retinal analogue in
which the methyl group in the C13 hydrocarbon chain was
substituted for an ethyl group (Figure 2). This extra group in
position C13 of the retinal was conceived to facilitate the
interaction with the alanine residue in the T90A mutant,
mimicking the lost steric interaction between Thr90 and the
C13-methyl moiety of the retinal molecule. Interestingly, our
protein design attempt did not recover the WT phenotype, giving
indirect evidence for the importance of the hydrogen bonding
interactions established by Thr90 [19,20].
In our previous studies and through several observations, it has
been already shown that the T90A mutation distorted the excitation
of the retinal in kept in the darkness, as well as the retinal isomeric
composition in light-adapted conditions. In the present study, we
show how the extra space for the accommodation of the
chromophore in the RBP provided by the mutation favors the 13-
cis retinal isomer (Figure S1), impairing the isomerization to all-trans,
necessary for the proton transport [32]. In the WT the bulkier C13
group of the 13E-RET analogue may collide with the side-chains
configuring the RBP, promoting an abnormal dark adaptation. This
seems to indicate that the residues in close contact with the C13 group
of the retinal molecule (Trp182, Leu93, Tyr185 and Thr90) are
essential for the retinal isomerization and consequently a normal
photocycle [9,36]. In our study, distorted kinetics for O intermediate
and BR recovery in WT and T90A bOps reconstituted with 13E-
RET could be due to an altered interaction of the retinal analogue
with Leu-93, and the Thr-90 in the case of the reconstituted WT-
bOp. Leu-93 interacts with the 13-methyl group of retinal [37] in
a similar manner that Thr-90. The bulkier ethyl group in the
analogue could modify that interaction that seems to influence the
reisomerization of the retinal during the photocycle at the NRO
step. In the L93A mutant there is a long-living O intermediate and
a slow N recovery [37,38]. Toth-Boconadi et al. [38] postulated the
presence of two O intermediates in the photocycle of L93A, one
short-living with 13-cis-retinal configuration, and a late O in-
termediate with a twisted all-trans-retinal conformation that was
detected also in WT bR cycle. The lost interaction between the
terminal methyl groups of Leu-93 and the 13-methyl of retinal in
L93A would hinder the retinal reisomerization. A bulkier group in
the retinal analogue at C13 could explain those alterations observed
Figure 4. Chemical stability denaturation experiments. A. Kinetics of retinal hydrolysis of the four chromoproteins by hydroxylamine
hydrochloride. The molar ratio protein/NH2OH was 1:4000. The measurements were done in 5 mM phosphate buffer pH 7.5 in the dark. B.
Absorbance spectra of the denaturation process (upper panels) compared to the minus second derivative of the absorbance spectra (lower panels)
for each reconstituted protein (as indicated in the figure). For sake of clarity, initial, mid and final spectra of the reaction are plotted with thicker lines.
doi:10.1371/journal.pone.0042447.g004
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in the photocycle of WT-13E-RET and T90A-13E-RET. Similarly,
the loss of the interaction between the 13-methyl group of retinal and
Thr-90 in T90A mutant would explain the distorted equilibrium of
the retinal isomerization in the LA form (Figure S1) and the
alteration in the photocycle observed in T90A-AT. Nevertheless, the
L93A mutant does not show any decrease in the proton transport
efficiency [37], as observed for the T90A mutant [20]. In contrast to
the T90A mutant, the RBP of the T90V is slightly better suited to
accommodate the all-trans-retinal, restoring an additional 10% the
proton transport pumping of bR when compared to T90A [20]. This
is not observed in the T90A-13E-RET, in which the proton
transport remains around 10% of WT. This lack of accommodation
of the retinal in T90A is also translated into the Asp85 behavior,
where the constraints introduced in the RBP by the 13E-RET
analogue facilitates the protonation of Asp85, shifting its pKa to
higher values. This is also coherent with the faster appearance of the
M intermediate in the photocycle of T90A (Fig. 5), where the SB
proton is transferred to Asp85.
The active site functionality and stability depend on the
presence of crucial hydrophilic residues embedded in the
hydrophobic core of a transmembrane protein [39]. As shown
here, the chemical and thermal stability of the RBP are
compromised in WT by incorporating a bulkier chromophore
that clashes with the CcThr90, likely pointing the hydroxyl group of
Thr90 in orientations that hinder the polar interactions with
Asp115 and Trp86, recreating the behavior of the T90A mutant.
However, the biphasic transition shown by the WT in the thermal
release of both the AT and 13E-RET molecules, also indicates that
the presence of the CcThr90 is required for the proper accommo-
dation of both retinal molecules. The incorporation of a bulkier
chromophore in the RBP of the T90A accommodates slightly
better the new chromophore by imitating the van der Waals
interaction. Therefore, any change of volume, either increment or
reduction, in the retinal vicinity affects the stability and
functionality of the protein significantly [40,41,42]. This is
reflected in the broad absorbance of the retinal of T90A in the
chemical/thermal denaturation experiments, extending well until
the 700 nm spectral region, suggesting heterogeneity in the retinal
environment. The fact that the steric interaction of Ala90 with the
retinal analogue is not enough to recover the functionality of the
protein, is due most probably to the absence of the hydrogen bond
network established by residue 90; that is, including a bulkier
group at the retinal’s C13 in T90A eases slightly the accommo-
dation of the analog in the retinal pocket, but has no beneficial
effect on the function.
Recently, Joh et al. have determined the structures of the
D115A and T90A/D115A mutants showing that the contribution
to stability of the Thr90-Asp115 hydrogen bond is modest,
although it corresponds to the strongest interactions among the
studied hydrogen bonds [21]. However, the T90A mutant is so
unstable that could not be crystallized (as we demonstrated earlier
through a variety of biophysical techniques). This is an interesting
Figure 5. Thermal stability denaturation experiments. A. Kinetics of retinal release by thermal denaturation from suspensions of 10 mM wt-
bOp and T90A-bOp reconstituted with AT and 13E-RET in 50 mM phosphate buffer. The chromoproteins were heated with an increment of 5uC and
a stabilization time of 8 minutes before acquiring the absorbance spectrum. B. Absorbance spectra of the denaturation process (upper panels)
compared to the minus second derivative of the absorbance spectra (lower panels) for each reconstituted protein (as indicated in the figure). For sake
of clarity, initial, mid and final spectra of the reaction are plotted with thicker lines.
doi:10.1371/journal.pone.0042447.g005
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observation, because it evidences the important alterations of
Asp115 in the T90A mutant. From FTIR measurements, it was
shown that unlike in WT Asp115 is deprotonated in the T90A
mutant at neutral and even at slightly alkaline pH [20]. Therefore,
in the WT the interaction of Asp115 with Thr90 controls the pKa
of Asp115 and stabilizes its protonated form. In T90A, the
presence of the negative charge of the deprotonated Asp115
embedded in a transmembrane hydrophobic core is likely to
impair not only the stability (our experimental data [20] and
Bowie’s Lab [21]), but also the dynamics of T90A (our
experimental data [19,20]). On the other hand, the expression
yield of T90A mutant compared to WT shows a 10-fold decrease
(data not shown) that may be representative of a restrictive folding
in the membrane. The 2D-arrangement of bR may be sufficient to
compensate partially this negative polar charge embedded in the
membrane through lipid-protein interactions. Additionally, it is
feasible that the water network is rearranged and extended to
compensate this charge in some measure, disturbing the proton
path and affecting the function. From a dynamics perspective (the
photocycle), our previous results [19,20,22] agree with this view,
showing that the Thr90-Asp115 hydrogen bond and the hydrogen
bond network established in the hydrophobic core of bR, are
essential for the propagation of the signal from the RBP to the rest
of the protein. Our present results indirectly reinforce the
importance of these hydrogen bonds, since restoring the steric
interaction at the level of the C13 of retinal adds nothing to the
function of the reconstituted protein.
Supporting Information
Figure S1 Retinal isomer composition analysis. HPLC of
Dark and light adapted (DA and LA) T90A (black lines) and WT
(grey lines) showing there is not light adaptation for the mutant.
(TIF)
Figure S2 Dark-light adaptation. Dark-light adaptation of
the four chromoproteins at 10 mM in 50 mM phosphate buffer at
pH 6.5. The differences in scattering are due to the aggregation
during the time of dark adaptation (more than one month).
(TIF)
Figure S3 Dark-light adaptation. Difference spectra be-
tween the light and the dark-adapted form of a 10 mM suspension
of the four chromoproteins in 50 mM phosphate buffer. The
suspensions have been kept in dark conditions for more than
a month and a spectrum of each protein was acquired. Afterwards
the suspension was illuminated for one minute at maximum
intensity and another spectrum was recorded.
(TIF)
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Figure 6. Photocycle characterization. Flash-induced transient absorbance change of a 15 mM protein suspension of the four chromoproteins at
410 nm (M), 660 nm (O) and 570 nm (BR). The samples were prepared in 3 mM phosphate buffer and 150 mM KCl at pH 7 and illuminated before
starting the measurements to allow light adaptation. As indicated in the plot, upper panels: T90A-AT (grey circles and grey fitting line) and T90A-13E-
RET (black circles and black fitting line); lower panels: WT-AT (grey circles and grey fitting line) and WT-13E-RET (black circles and black fitting line).
doi:10.1371/journal.pone.0042447.g006
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Supporting Materials and Methods 
 
HPLC Analysis.  
HPLC analysis of the retinal isomeric state of WT and T90A was performed as 
described previously (ref), using DA (five weeks in darkness at 4 oC) and LA samples. 
First, the retinal was hydrolyzed and released at 4 oC by adding bR to an excess of 
methanol solution and 500 mM hydroxylamine. The formed retinal oximes were 
transferred to hexane, and loaded to a high-performance liquid chromatograph (HPLC) 
equipped with a silica column (6.0×150 mm; YMC-Pack SIL). The elution solvent 
(flowing at 1.0 mL/min) was composed of 12% (v/v) ethyl acetate and 0.12% (v/v), and 
the absorbance at 360 nm was recorded as a function of the retention time. Assignment 
of the peaks to retinal isomers was performed by comparing them with previously 
recorded patterns from retinal oximes of authentic all-trans- and 13-cis-retinals 
(Kawanabe et al. 2006). The whole process was performed under dim red light 
conditions. 
 
Kawanabe A, Furutani Y, Jung KH, Kandori H. FTIR study of the photoisomerization 
processes in the 13-cis and all-trans forms of Anabaena sensory rhodopsin at 77 K. 
Biochemistry. 2006 Apr 11;45(14):4362-70. 
 
Experimental Section for Synthesis 
General. Solvents were dried according to published methods and distilled before use. 
HPLC grade solvents were used for the HPLC purification. All other reagents were 
commercial compounds of the highest purity available. All reactions were carried out 
under argon atmosphere, and those not involving aqueous reagents were carried out in 
oven-dried glassware. Analytical thin layer chromatography (TLC) was performed on 
aluminium plates with Merck Kieselgel 60F254 and visualised by UV irradiation (254 
nm) or by staining with solution of phosphomolibdic acid. Flash column 
chromatography was carried out using Merck Kieselgel 60 (230-400 mesh) under 
pressure. High performance liquid chromatography was performed using a Waters 




HR silica, 60 Å, 19 x 300 mm and 95:5 hexane/ethyl acetate as eluent. UV/Vis spectra 
were recorded on a Cary 100 Bio spectrophotometer using MeOH as solvent. Infrared 
spectra were obtained on JASCO FT-IR 4200 spectrophotometer, from a thin film 
deposited onto a NaCl glass. Specific rotation was obtained on JASCO P-1020. Mass 
spectra were obtained on a Hewlett-Packard HP59970 instrument operating at 70 eV by 
electron ionisation. High Resolution mass spectra were taken on a VG Autospec 
instrument. 1H NMR spectra were recorded in CDCl3, C6D6 and (CD3)2CO at ambient 
temperature on a Bruker AMX-400 spectrometer at 400 MHz with residual protic 
solvent as the internal reference (CDCl3, δH = 7.26 ppm; C6D6, δH = 7.16 ppm; 
(CD3)2CO, δH = 2.05 ppm); chemical shifts (δ) are given in parts per million (ppm), and 
coupling constants (J) are given in Hertz (Hz). The proton spectra are reported as 
follows: δ (multiplicity, coupling constant J, number of protons, assignment). 13C NMR 
spectra were recorded in CDCl3, C6D6 and (CD3)2CO at ambient temperature on the 
same spectrometer at 100 MHz, with the central peak of CDCl3 (δC = 77.0 ppm), C6D6 
(δC = 128.0 ppm) or (CD3)2CO (δC = 30.8 ppm) as the internal reference. DEPT135 are 
used to aid in the assignment of signals in the 13C NMR spectra. 
(2E,4E,6E)-8-(tert-Butyldiphenylsilanyloxy)-6-ethyl-2-methyl-octa-2,4,6-trien-1-ol 7. 
To a cooled (0 °C) solution of (2E,4E,6E)-6-bromo-8-tert-butyldiphenylsilanyloxy)-2-
methyl-octa-2,4,6-trien-1-ol 2 (0.116 g, 0.25 mmol) and NiCl2dppp (0.014 g, 0.025 
mmol) in THF (2.5 mL) in a sealed tube, EtMgBr (0.741 mL, 1M in THF, 0.741 mmol) 
was added. After stirring at 40 °C for 4h, EtOH was added (3 mL) and the mixture was 
filtered and concentrated. The residue was purified by column chromatography (silica 
gel, 95:5 hexane/ethyl acetate) to afford 0.068 g of a yellow oil (66%) which was 
identified as (2E,4E,6E)-8-(tert-butyldiphenylsilanyloxy)-6-ethyl-2-methyl-octa-2,4,6-
trien-1-ol 7. 1H-NMR (400.16 MHz, C6D6): δ 7.9-7.8 (m, 4H, ArH), 7.3-7.2 (m, 6H, 
ArH), 6.54 (dd, J = 15.3, 10.9 Hz, 1H, H4), 6.34 (d, J = 15.3 Hz, 1H, H5), 5.96 (d, J = 
10.7 Hz, 1H, H3), 5.73 (t, J = 6.2 Hz, 1H, H7), 4.56 (d, J = 6.4 Hz, 2H, 2H8), 3.69 (d, J = 
3.7 Hz, 2H, 2H1), 2.20 (q, J = 7.4 Hz, 2H, C6-CH2CH3), 1.58 (s, 3H, C2-CH3), 1.19 (s, 
9H, Si(CH3)3), 1.05 (t, J = 7.4 Hz, 3H, C6-CH2CH3) ppm. 13C-NMR (100.62 MHz, 
CDCl3): δ 139.8 (s), 137.4 (s), 135.5 (d, 4x), 133.8 (s, 2x), 129.6 (d, 2x), 128.6 (d), 
127.7 (d), 127.5 (d, 4x), 125.6 (d), 124.6 (d), 68.4 (t), 60.4 (t), 26.7 (q, 3x), 26.2 (t), 19.1 
(s), 14.2 (q), 13.2 (q) ppm. MS (FAB+): m/z (%) 421 ([M+1]+, 6), 420 (M+, 13), 419 
(12), 404 (10), 403 (29), 307 (15), 289 (11), 239 (11), 235 (10), 200 (18), 199 (100), 
198 (12), 197 (51). HRMS (FAB+): Calcd. for C27H36O2Si ([M]+) 420.2485; found, 
420.2484. IR (NaCl): ν 3500-3100 (br, O-H), 2960 (s, C-H), 2929 (s, C-H), 2856 (m, 
C-H), 1670, 1470, 1110 cm-1. UV (MeOH): λmax 280 nm. 
 
(2E,4E,6E)-8-(tert-Butyldiphenylsilanyloxy)-6-ethyl-2-methylocta-2,4,6-trien-1-al 4. To 
a solution of (2E, 4E, 6E)-8-(tert-butyldiphenylsilanyloxy)-6-ethyl-2-methyl-octa-2,4,6-
trien-1-ol 7 (0.101 g, 0.24 mmol) in CH2Cl2 (6 mL) was added MnO2 (0.38 g, 4.32 
mmol) and the suspension was stirred for 3h. The mixture was filtered throught Celite 
and the solvents were removed. The residue was purified by column chromatography 
(silica gel, 95:5 hexane/ ethyl acetate) to afford 0.079 g of a yellow oil (79%) that was 
identified as (2E,4E,6E)-8-(tert-butyldiphenylsilanyloxy)-6-ethyl-2-methyl-octa-2,4,6-
trien-1-ol 4. 1H-NMR   (400.13 MHz, C6D6): δ 9.37 (s, 1H, H1), 7.9-7.8 (m, 4H, ArH), 
7.3-7.2 (m, 6H, ArH), 6.4-6.3 (m, 2H, H4 + H5), 6.2-6.1 (m, 1H, H3), 5.82 (t, J = 6.4 Hz, 
1H, H7), 4.48 (d, J = 6.4 Hz, 2H, 2H8), 2.02 (q, J = 7.4 Hz, 2H, C6-CH2CH3), 1.73 (d, J 
= 1.1 Hz, 3H, C2-CH3), 1.19 (s, 9H, Si(CH3)3), 0.94 (t, J = 7.4 Hz, 3H, C6-CH2CH3) 
ppm. 13C-NMR (100.62 MHz, (CD3)2CO): δ 194.8 (d), 149.6 (d), 140.0 (s), 138.6 (s), 
 3 
137.7 (s), 136.5 (d, 4x), 134.6 (s, 2x), 133.4 (d), 130.9 (d, 2x), 128.9 (d, 4x), 125.8 (d), 
61.3 (t), 27.4 (q, 3x), 26.8 (t), 19.9 (s), 13.8 (q), 9.7 (q) ppm. MS (FAB+): m/z (%) 419 
([M+1]+, 18), 418 (M+, 15), 417 (14), 361 (21), 239 (13), 221 (12), 200 (18), 199 (96), 
198 (12), 197 (51), 183 (15), 165 (16), 164 (20), 163 (100). HRMS (FAB+): Calcd. for 
C27H35O2Si [(M+1)+], 419.2406; found, 419.2413. IR (NaCl): ν 2961 (s, C-H), 2930 (s, 
C-H), 2857 (m, C-H), 1675 (s, C=O), 1612, 1111 cm-1. UV (MeOH): λmax 319 nm. 
 
(2E,4E,6E,8E)-tert-Butyl-[3-ethyl-7-methyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-
2,4,6,8-tetraen-1-yl]diphenylsilane 5. A cooled (-30 ºC) emulsion of triphenyl-(2,6,6-
trimethylcyclohex-1-enylmethyl)phosphonium bromide 3 (0.182 g, 0.38 mmol) in THF 
(4 mL) was treated with n-BuLi (0.270 mL, 1.41 M in hexanes, 0.38 mmol) and stirred 
for 30 min. The mixture was cooled down to -78 °C and a solution of (2E,4E,6E)-8-
(tert-butyldiphenylsilanyloxy)-6-ethyl-2-methyl-octa-2,4,6-trien-1-ol 4 (0.133 g, 0.32 
mmol) in THF (4 mL) was added. The resulting mixture was allowed to warm to 25 °C 
for 14 h, and H2O (8 mL) was added. The reaction was extracted with Et2O (3x) and the 
organic layers were washed with brine (3x), dried (Na2SO4) and the solvent was 
evaporated. The residue was purified by column chromatography (silica gel, hexane) to 
afford 0.12 g (70%) of a yellow oil identified as (2E,4E,6E,8E)-tert-butyl-[3-ethyl-7-
methyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl]diphenylsilane 5 
and 0.024 g (16%) of another yellow oil identified as (6E,8E,10E)-12-(tert-
butyldiphenylsilanyl)-10-ethyl-6-methyl-dodeca-6,8,10-trien-5-ol 6. Data for 
(2E,4E,6E,8E)-tert-butyl-[3-ethyl-7-methyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-
2,4,6,8-tetraen-1-yl]diphenylsilane 5: 1H-NMR (400.16 MHz, C6D6): δ 7.9-7.8 (m, 4H, 
ArH), 7.2-7.1 (m, 6H, ArH), 6.71 (dd, J = 15.2, 11.2 Hz, 1H, H11), 6.35 (d, J = 15.2 Hz, 
1H, H12), 6.28 (m, 2H, H7 + H8), 6.04 (d, J = 11.2 Hz, 2H, H10), 5.75 (t, J = 6.4 Hz, 1H, 
H14), 4.57 (d, J = 6.4 Hz, 2H, 2H15), 2.21 (q, J = 7.5 Hz, 2H, C13-CH2CH3), 2.0-1.9 (m, 
2H, 2H4), 1.84 (s, 3H, C9-CH3), 1.80 (s, 3H, C5-CH3), 1.6-1.5 (m, 2H, 2H3), 1.5-1.4 (m, 
2H, 2H2), 1.20 (s, 9H, Si(CH3)3), 1.13 (s, 6H, C1-(CH3)2), 1.06 (t, J = 7.4 Hz, 3H, C13-
CH2CH3) ppm. 13C-NMR (100.62 MHz, (CD3)2CO): δ 139.5 (s), 137.7 (d), 137.6 (s), 
135.7 (s, 2x), 135.3 (d, 4x), 133.6 (s), 130.8 (d), 129.6 (d, 2x), 128.7 (s), 128.2 (d), 
127.6 (d, 4x), 127.4 (d), 126.4 (d), 125.9 (d), 60.2 (t), 39.3 (t), 33.8 (s), 32.6 (t), 29.7 (q), 
28.3 (q), 26.2 (q, 3x), 26.0 (t), 20.9 (q), 18.9 (t), 18.7 (s), 12.9 (q), 11.7 (q) ppm. MS 
(FAB+): m/z (%) 539 ([M+1]+, 30), 538 ([M]+, 62), 537 (10), 481 (10), 348 (21), 283 
(41), 281 (10), 269 (25), 239 (11), 213 (10), 201 (12), 200 (19), 199 (100), 198 (19), 
197 (88), 195 (10). HRMS (FAB+): Calcd. for C12H51OSi ([M+1]+), 539.3709; found, 
539.3702. IR (NaCl): ν 3360, 2924 (s, C-H), 2854 (s, C-H), 1654, 1633 cm-1. UV 
(MeOH): λmax 329nm. Data for (6E,8E,10E)-12-(tert-butyldiphenylsilanyl)-10-ethyl-6-
methyl-dodeca-6,8,10-trien-5-ol 6: 1H-NMR (400.13 MHz, CDCl3): δ 7.7-7.6 (m, 4H, 
ArH), 7.4-7.3 (m, 6H, ArH), 6.42 (dd, J = 15.3, 10.8 Hz, 1H, H8), 6.20 (d, J = 15.3 Hz, 
1H, H9), 5.96 (d, J = 10.8 Hz, 2H, H7), 5.54 (t, J = 6.3 Hz, 1H, H11), 4.39 (d, J = 6.4 Hz, 
2H, 2H12), 4.02 (t, J = 6.6 Hz, 1H, H5), 2.23 (q, J = 7.4 Hz, 2H, C10-CH2CH3), 1.75 (s, 
3H, C6-CH3), 1.6-1.5 (m, 2H, 2H4), 1.4-1.3 (m, 2H, 2H3), 1.3-1.2 (m, 2H, 2H2), 1.07 (t, 
J = 7.4 Hz, 3H, C10-CH2CH3), 1.05 (s, 9H, Si(CH3)3), 0.90 (t, J = 7.0 Hz, 3H, H1) ppm. 
13C-NMR (100.62 MHz, CDCl3): δ 140.2 (s), 139.0 (s), 135.6 (d, 4x), 133.9 (s, 2x), 
132.5 (d, 2x), 128.7 (d), 127.8 (d), 127.6 (d, 4x), 126.2 (d), 124.7 (d), 77.7 (d), 60.5 (t), 
34.7 (t), 27.8 (t), 26.8 (q, 3x), 26.3 (t), 22.6 (t), 19.2 (s), 14.0 (q), 13.29 (q), 12.1 (q) 
ppm. MS (FAB+): m/z (%) 477 ([M+1]+, 11), 476 ([M]+, 11), 475 (11), 460 (17), 459 
(42), 419 (18), 267 (17), 239 (10), 221 (13), 204 (15), 203 (66), 199 (100), 198 (13), 
197 (57). HRMS (FAB+): Calcd. for C31H44O2Si, ([M]+), 476.3111; found, 476.3120. 
 4 
IR (NaCl): ν 3450-3100 (br, O-H), 2959 (s, C-H), 2931 (s, C- H), 2858 (m, C-H), 1428, 
1111 cm-1. UV (MeOH): λmax 282 nm 
 
13-Ethylretinal 1. A cooled (0 °C) solution of (2E,4E,6E,8E)-tert-butyl-[3-ethyl-7-
methyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl]diphenylsilane 5 
(26.9 mg, 0.05 mmol) in THF (0.45 mL) was treated with n-Bu4NF (0.075 mL, 1 M in 
THF, 0.075 mmol) and stirred for 2 h. The mixture was diluted with Et2O (1 mL) and 
washed with an aqueous solution of NaHCO3 (1x). The aqueous layer was extracted 
with Et2O (3x) and the combinated organic layers were washed with brine (3x), dried 
(Na2SO4) and concentrated. The residue was used without further purification. To a 
solution of this compound in CH2Cl2 (1 mL) was added MnO2 (78 mg, 0.9 mmol) and 
Na2CO3 (95 mg, 0.9 mmol), and the suspension was stirred at room temperature for 3 h. 
The mixture was filtered through Celite and the solvent was removed. The residue was 
purified by column chromatography (silica gel, 95:5 hexane/ethyl acetate) to afford 9.1 
mg (60%, both steps) of a yellow oil identified as a mixture of (13E)-13-ethylretinal 1 
and (13Z)-13-ethylretinal (13Z)-1 in a 2:1 13E/13Z ratio which were separated by 
HPLC. Data for (13E)-13-ethylretinal 1: 1H-NMR (400.13 MHz, C6D6): δ 10.04 (d, J = 
7.7 Hz, 1H, H15), 6.93 (dd, J = 15.2, 11.4 Hz, 1H, H11), 6.35 (d, J = 16.2 Hz, 1H, H7), 
6.26 (d, J = 16.2 Hz, 1H, H8), 6.03 (d, J = 11.4 Hz, 1H, H10), 6.0-5.9 (m, 2H, H12 + H14), 
2.35 (q, J = 7.6 Hz, 2H, C13-CH2CH3), 2.0-1.9 (m, 2H, 2H4), 1.77 (s, 3H, C9-CH3), 1.76 
(s, 3H, C5-CH3), 1.6-1.5 (m, 2H, 2H3), 1.5-1.4 (m, 2H, 2H2), 1.12 (s, 6H, C1-(CH3)2), 
0.91 (t, J = 7.4 Hz, 3H, C6-CH2CH3) ppm. 13C-NMR (100.62 MHz, (CD3)2CO): δ 190.0 
(d), 160.7 (s), 140.4 (s), 137.5 (s), 137.3 (d), 133.3 (d), 131.9 (d), 129.9 (d), 129.6 (s), 
128.8 (d), 127.6 (d), 39.3 (t), 33.9 (s), 32.6 (t), 28.2 (q, 2x), 20.9 (q), 19.8 (t), 18.8 (t), 
15.1 (q), 12.0 (q) ppm. MS (EI+): m/z (%) 298 ([M]+, 22), 236 (14), 173 (13), 137 (18), 
136 (12), 135 (12), 123 (14), 121 (18), 119 (15), 111 (14), 109 (18), 107 (13), 105 (11), 
98 (12), 97 (27), 96 (15), 95 (30), 93 (14), 91 (11), 85 (17), 83 (33), 82 (20), 81 (57), 72 
(19), 71 (29), 70 (16), 69 (100). HRMS (EI+): Calcd. para C21H30O ([M]+), 298.2297; 
found, 298.2293. IR (NaCl): ν 2961 (s, C-H), 2927 (s, C-H), 2863 (m, C-H), 1660 (s, 
C=O), 1578, 1116 cm-1. UV (MeOH): λmax 383 (22700) nm. Data for (13Z)-13-
ethylretinal (13Z)-1: 1H-NMR (400.13 MHz, C6D6): δ 10.19 (d, J = 7.5 Hz, 1H, H15), 
6.96 (d, J = 15.0 Hz, 1H, H12), 6.81 (dd, J = 15.0, 11.2 Hz, 1H, H11), 6.37 (d, J = 16.2 Hz, 
1H, H7), 6.29 (d, J = 16.1 Hz, 1H, H8), 6.06 (d, J = 11.2 Hz, 1H, H10), 5.83 (d, J = 7.6 
Hz, 1H, H14), 2.00 (q, J = 7.4 Hz, 2H, C13-CH2CH3), 2.0-1.9 (m, 2H, 2H4), 1.79 (s, 3H, 
C9-CH3), 1.78 (s, 3H, C5-CH3), 1.6-1.5 (m, 2H, 2H3), 1.5-1.4 (m, 2H, 2H2), 1.33 (s, 6H, 
C1-(CH3)2), 0.84 (t, J = 7.4 Hz, 3H, C13-CH2CH3) ppm. 1H-NMR (400.13 MHz, 
(CD3)2CO): δ 10.27 (d, J = 7.7 Hz, 1H, H15), 7.42 (d, J = 15.1 Hz, 1H, H12), 7.23 (dd, J 
= 15.1, 11.3 Hz, 1H, H11), 6.40 (d, J = 15.9 Hz, 1H, H7), 6.35 (d, J = 11.4 Hz, 1H, H10), 
6.24 (d, J = 16.1 Hz, 1H, H8), 5.81 (d, J = 7.8 Hz, 1H, H14), 2.57 (q, J = 7.5 Hz, 2H, C13-
CH2CH3), 2.07 (s, 3H, C9-CH3), 2.1-2.0 (m, 2H, 2H4), 1.74 (s, 3H, C5-CH3), 1.7-1.6 (m, 
2H, 2H3), 1.6-1.5 (m, 2H, 2H2), 1.19 (t, J = 7.5 Hz, 3H, C13-CH2CH3), 1.06 (s, 6H, C1-
(CH3)2) ppm. 13C-NMR (100.62 MHz, (CD3)2CO): δ 189.5 (d), 159.5 (s), 140.3 (s), 
137.5 (s), 137.3 (d), 132.5 (d), 130.0 (d), 129.5 (s), 128.7 (d), 126.0 (d), 125.9 (d), 39.3 
(t), 33.8 (s), 32.6 (t), 28.2 (q, 2x), 26.5 (t), 20.9 (q, C5-CH3), 18.8 (t), 12.9 (q), 11.9 (q) 
ppm. MS (EI+): m/z (%) 299 ([M+1]+, 23), 298 ([M]+, 100), 283 (13), 269 (13), 173 
(29), 159 (11), 145 (11), 133 (13), 131 (11), 119 (20), 109 (13), 105 (18), 95 (14), 91 
(19). HRMS (EI+): Calcd. For C21H30O, 298.2297 ([M]+); found, 298.2294. IR (NaCl): 
ν 2960 (s, C-H), 2927 (s, C-H), 2863 (m, C-H), 1661 (s, C=O), 1578, 1117 cm-1. UV 
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